19 results on '"Li, S.C."'
Search Results
2. Cost-Effectiveness of Treating Acute Coronary Syndrome Patients with Rivaroxban in Australia
3. Challenges and Opportunities in the Malaysian Health Care System
4. PHP92 - HOT ISSUES ABOUT DRUG PRICE IN CHINA: FROM THE VIEW OF INTERNET PUBLIC OPINION MONITORING
5. Validation of a chinese version of neuropsychiatry unit cognitive assessment tool (NUCOG)
6. PHP4 Pharmaceutical Care Intervention for Disease Management in Community Pharmacies in Australia
7. PDB27 Cost-Utility Analysis of Liraglutide Versus Glimepiride As Add-on to Metformin in Patients with Type 2 Diabetes in China
8. PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials
9. PHP87 Satisfaction Assessment of Insurance System for Urban Residents (URMS) of University Students in Shenyang
10. PRM6 Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis
11. PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Exploring Impacts of Herd Immunity and Patterns of Breastfeedingof
12. PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Results and Challenges
13. PRM4 WHAT IS IMPORTANT DURING THE PHARMACOECONOMIC EVALUATION OF CAM (COMPLEMENTARY AND ALTERNATIVE MEDICINE)?—A SURVEY RESEARCH
14. PHP97 - Challenges and Opportunities in the Malaysian Health Care System
15. PCV28 - Cost-Effectiveness of Treating Acute Coronary Syndrome Patients with Rivaroxban in Australia
16. PND9 - Validation of a chinese version of neuropsychiatry unit cognitive assessment tool (NUCOG)
17. PHP97 Challenges and Opportunities in the Malaysian Health Care System
18. PND9 Validation of a chinese version of neuropsychiatry unit cognitive assessment tool (NUCOG)
19. PCV28 Cost-Effectiveness of Treating Acute Coronary Syndrome Patients with Rivaroxban in Australia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.